Windtree Therapeutics Inc

NASDAQ:WINT   10:41:25 AM EDT
1.80
+0.12 (+7.14%)
Earnings Announcements

Windtree Therapeutics Reports Q4 Loss Per Share $0.44

Published: 03/29/2021 21:37 GMT
Windtree Therapeutics Inc (WINT) - Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates.
Q4 Loss per Share $0.44.
As of Dec 30, 2020, Co Reported Cash, Cash Equivalents of $16.9 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.